GFI1(36N) as a therapeutic and prognostic marker for myelodysplastic syndrome

Autor: Botezatu, L, Michel, LC, Makishima, H, Schroeder, T, Germing, U, Haas, R, van der Reijden, B, Marneth, AE, Bergevoet, SM, Jansen, JH, Przychodzen, B, Wlodarski, M, Niemeyer, C, Platzbecker, U, Ehninger, G, Unnikrishnan, A, Beck, D, Pimanda, J, Hellström-Lindberg, E, Cazzola, M, Malcovati, L, Boultwood, J, Pellagatti, A, Papaemmanuil, E, Le Coutre, P, Kaeda, J, Opalka, B, Möröy, T, Dührsen, U, Maciejewski, J, Khandanpour, C

Publikováno v: Experimental Hematology, 44, 7, pp. 590-595
Experimental Hematology, 44, 590-595
Experimental Hematology

Inherited gene variants play an important role in malignant diseases. The transcriptional repressor growth factor independence 1 (GFI1) regulates hematopoietic stem cell (HSC) self-renewal and differentiation. A single-nucleotide polymorphism of GFI1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0e5a347425cdd518235ffe37e0bbaf2
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/172597

Gray and White Matter Metrics Demonstrate Distinct and Complementary Prediction of Differences in Cognitive Performance in Children: Findings from ABCD ( N  = 11,876).

Autor: Michel LC; Cognitive Neuroscience Department, Radboud University Medical Center, Nijmegen 6525 GA, The Netherlands lea.michel@radboudumc.nl., McCormick EM; Cognitive Neuroscience Department, Radboud University Medical Center, Nijmegen 6525 GA, The Netherlands.; Methodology and Statistics, Institute of Psychology, Leiden University, Leiden 2333 AK, The Netherlands.; Department of Psychology and Neuroscience, University of North Carolina, Chapel Hill, North Carolina 27599-3270., Kievit RA; Cognitive Neuroscience Department, Radboud University Medical Center, Nijmegen 6525 GA, The Netherlands.

Publikováno v: The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 2024 Mar 20; Vol. 44 (12). Date of Electronic Publication: 2024 Mar 20.

Changes to same day discharge after minimally invasive hysterectomy throughout COVID-19 pandemic.

Autor: Sullivan ME; Stamford Hospital, Stamford, Connecticut, USA., Michel LC; Maimonides Medical Center, Brooklyn, New York, USA., Wasser T; Stamford Hospital, Stamford, Connecticut, USA., Clark M; Yale University, New Haven, Connecticut, USA., Chudnoff S; Maimonides Medical Center, Brooklyn, New York, USA., Andikyan V; Yale University, New Haven, Connecticut, USA.

Publikováno v: The journal of obstetrics and gynaecology research [J Obstet Gynaecol Res] 2023 May; Vol. 49 (5), pp. 1418-1423. Date of Electronic Publication: 2023 Feb 18.

Epigenetic therapy as a novel approach for GFI136N-associated murine/human AML.

Autor: Botezatu L; Department of Hematology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany., Michel LC; Department of Hematology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany., Helness A; Institut de recherches cliniques de Montréal (IRCM), Montréal, QC, Canada., Vadnais C; Institut de recherches cliniques de Montréal (IRCM), Montréal, QC, Canada., Makishima H; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH., Hönes JM; Department of Hematology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany., Robert F; Institut de recherches cliniques de Montréal (IRCM), Montréal, QC, Canada; Département de médecine, Faculté de médecine, Université de Montréal, Montréal, QC, Canada., Vassen L; Department of Hematology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany., Thivakaran A; Department of Hematology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany., Al-Matary Y; Department of Hematology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany., Lams RF; Department of Hematology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany., Schütte J; Department of Hematology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany., Giebel B; Institute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Görgens A; Institute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Medyouf H; Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany., Maciejewski J; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH., Dührsen U; Department of Hematology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany., Möröy T; Institut de recherches cliniques de Montréal (IRCM), Montréal, QC, Canada; Department of Hematology and Oncology, University Hospital Düsseldorf, Düsseldorf, Germany; Département de microbiologie, infectiologie et immunologie, Université de Montréal, Montréal, QC, Canada. Electronic address: Tarik.Moroy@ircm.qc.ca., Khandanpour C; Department of Hematology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany. Electronic address: cyrus.khandanpour@uk-essen.de.

Publikováno v: Experimental hematology [Exp Hematol] 2016 Aug; Vol. 44 (8), pp. 713-726.e14. Date of Electronic Publication: 2016 May 20.